STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma

Preprint | 
10.55415/deep-2023-0039.v2
This is not the most recent version. There is anewer versionof this content available.
Feng Bo#
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China++School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China++School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China
Xiao Lu
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China
Guangqin Zhang
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China
Libo Zhao
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China
Mei Dong*
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of China
Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of China

# contributed equally to this work, * Corresponding author


Abstract

Abstract 


 Neuroblastoma (NB) is a common solid tumor in children and infants, with its formation and regression closely linked to the tumor-host immune mechanism. STING agonists, particularly cyclic dinucleotide (CDN), have promising potential in NB therapy by generating innate and adaptive immune stimulation, leading to tumor control. In vivo CDN delivery is challenging due to its negative charge, hydrophilicity, and susceptibility to degradation by phosphodiesterase, hindering its effectiveness. Thus, our study proposed four methods to load CDN into liposomes, using 2',3'-cGAMP as the model drug. Lipid nanoparticles were prepared, followed by physicochemical characterization. Subsequently, cellular inhibition and immune stimulation were investigated. As a result, lipid calcium phosphate nanoparticles (LCP-NP) possessed the highest encapsulation efficiency among the four preparation methods, with a diameter of 82.57±3.72nm. LCP-NP maintained size stability under refrigeration conditions at 4°C within 48 hours. The surface of the liposome was positively charged. Compared with free cGAMP, LCP-NP resulted in a slower release, enhanced cytotoxicity against tumor cells, greater activation of the cGAS-STING pathway, and increased expression of the immune factors. These findings clearly demonstrated the effectiveness of the liposomal delivery system for cGAMP and provided a promising strategy for the treatment of NB.

Keywords
Subject Area
Version History
Scores
 0
Rapid Rating Times: 0
· Level of Quality: -
· Level of Repeatability: -
· Level of Innovation: -
· Level of Impact: -

*Each rating ranges from 0-5

Rapid Rating
Your professional field is different from the direction of this article. Go Settings!
  • Level of Quality
    Is the publication of relevance for the academic community and does it provide important insights? Is the language correct and easy to understand for an academic in the field? Are the figures well displayed and captions properly described? Is the article systematically and logically organized?
    0.0
  • Level of Repeatability
    Is the hypothesis clearly formulated? Is the argumentation stringent? Are the data sound, well-controlled and statistically significant? Is the interpretation balanced and supported by the data? Are appropriate and state-of-the-art methods used?
    0.0
  • Level of Innovation
    Does the work represent a novel approach or new findings in comparison with other publications in the field?
    0.0
  • Level of Impact
    Does the work have potential huge impact to the related research area?
    0.0
Submit

我们使用 cookie 将您与其他用户区分开来, 并在我们的网站上为您提供更好的体验。

关闭此消息以接受 cookie 或了解如何管理您的 cookie 设置。

了解更多关于我们的隐私声明..

goTop